Seminar Added!Dr. Frédérique Santerre Global Head, Access to Health (A2H) Merck Group on 9/29

in Conferences/Seminars, Events
September 24th, 2015

Join the Pharm Program for a seminar on Tuesday, September 29 from 5:00-5:50 in L311 as we welcome Dr. Frédérique Santerre.

Frédérique Santerre is Global Head of Access to Health, responsible for establishing a new cross -functional unit and leading global health and innovative access programs and initiatives internationally at Merck Group. She is in charge of CEO and senior management leadership engagement in global health and is responsible for the company’s representation and activities at the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), the Gates CEO Roundtable for Global Health and with global health stakeholders (e.g. UN, WHO, Global Fund, funders and philanthropies, NGOs, academia, think tanks and patients) on global health and access-related issues.

In her previous position, as Head of Global Government Affairs and Health Policy, she was responsible for government affairs and public policy globally for Merck Serono, the pharmaceutical division of the Merck Group. Prior to her arrival at Merck Serono, she was Director of the Health Care Systems & Global Health Policy at the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA). She also held various positions in international organizations, in academia, and in non-governmental organizations. In addition, she worked for the World Economic Forum (Davos). As a post-doctoral Research Fellow and Faculty member at Harvard University’s Kennedy School of Government in the Science, Technology and Society Program in Cambridge, MA, she ran two multi-disciplinary research projects on biotechnology regulation as well as provided mentorship to doctoral students. In parallel, she ran global health and public-private partnership consultancies with UN organisations.

Frédérique Santerre was born in Paris, France, and obtained a degree in economics from the Sorbonne University, master degrees in comparative politics from Glasgow University and in international relations from Geneva Graduate Institute, and her Ph.D. in International Relations from the Geneva Graduate Institute   of   International Studies.   Her   doctoral   dissertation   was   on   the   global   governance   of biotechnology. (Source – here)